Planta Med 2008; 74(12): 1436-1440
DOI: 10.1055/s-2008-1081349
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Thyme Extract, but not Thymol, Inhibits Endothelin-Induced Contractions of Isolated Rat Trachea

Jonas Engelbertz1 , Tatjana Schwenk1 , Ute Kinzinger2 , Detlef Schierstedt2 , Eugen J. Verspohl1
  • 1Department Pharmacology, Institute for Medicinal Chemistry, University of Münster, Münster, Germany
  • 2Krewel Meuselbach GmbH, Eitorf, Germany
Further Information

Publication History

Received: April 30, 2008 Revised: June 26, 2008

Accepted: July 8, 2008

Publication Date:
26 August 2008 (online)

Abstract

Thyme extract is known to posses spasmolytic effects on isolated trachea and to increase ciliary activity. A small part of this effect is mediated via β2 receptors, but other receptors are supposed to be involved. Endothelin has a pathophysiological impact in asthma with respect to hyper-reagibility and contracting isolated trachea smooth muscles and was, therefore, investigated. Thyme extract inhibited endothelin-induced contraction. Emax decreased depending on the concentration of thyme extract indicating a non-competitive inhibition. Bosentan, an endothelin receptor antagonist (positive control), acted as a competitive inhibitor. The interaction/combination of thyme extract and bosentan was additive but not supra-additive indicating an interaction with the endothelin system. Thymol (one of the major compounds of thyme extract) did not interact with the endothelin system. It is concluded that thyme extract may help in diseases related to endothelin hyper-reagibility of the bronchus system such as asthma and COPD (chronic obstructive pulmonary disease), although thymol is not involved in this effect.

References

  • 1 Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y. et al . A novel potent vasoconstrictor peptide produced by vascular endothelial cells.  Nature. 1988;  332 411-5
  • 2 Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K. et al . The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.  Proc Natl Acad Sci USA. 1989;  86 2863-7
  • 3 Kirchengast M, Witte K, Stolpe K, Schilling L, Nedvetsky P I, Schmidt H H. et al . Effects of chronic endothelin ET(A) receptor blockade on blood pressure and vascular formation of cyclic guanosine-3′,5′-monophosphate in spontaneously hypertensive rats.  Arzneimittelforschung/Drug Res. 2005;  55 498-504
  • 4 Hay D W, Douglas S A, Ao Z, Moesker R M, Self G J, Rigby P J. et al . Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout mice.  Br J Pharmacol. 2001;  132 1905-15
  • 5 D'Agostino B, Advenier C, Falciani M, Gallelli L, Marrocco G, Piegari E. et al . Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis induction.  Br J Pharmacol. 2001;  134 1447-54
  • 6 Filep J G, Battistini B, Sirois P. Pharmacological modulation of endothelin-induced contraction of guinea-pig isolated airways and thromboxane release.  Br J Pharmacol. 1991;  103 1633-40
  • 7 Yoneyama T, Hori M, Makatani M, Yamamura T, Tanaka T, Matsuda Y. et al . Subtypes of endothelin ETA and ETB receptors mediating tracheal smooth muscle contraction.  Biochem Biophys Res Commun. 1995;  207 668-74
  • 8 Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K. et al . A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8 – 21), IRL 1620, for the ETB receptor.  Biochem Biophys Res Commun. 1992;  184 953-9
  • 9 El-Mowafy A M, Biggs D F. ET(B) receptor activates adenylyl cyclase via a c-PLA(2)-dependent mechanism: a novel counterregulatory mechanism of ET-induced contraction in airway smooth muscle.  Biochem Biophys Res Commun. 2001;  286 388-93
  • 10 Zhang Y, Adner M, Cardell L O. Interleukin-1b attenuates endothelin B receptor-mediated airway contractions in a murine in vitro mdoel of asthma: roles of endothelin converting enzyme and mitogen-activated protein kinase pathways.  Clin Exp Allergy. 2004;  34 1480-7
  • 11 Granstrom B W, Xu C B, Nilsson E, Bengsson U H, Edvinsson L. Up-regulation of endothelin receptor function and mRNA expression in airway smooth muscle cells following Sephadex-induced airway inflammation.  Basic Clin Pharmacol Toxikcol. 2004;  95 43-8
  • 12 Chalmers G W, Little S A, Patel K R, Thomson N C. Endothelin-1-induced bronchoconstriction in asthma.  Am J Respir Crit Care Med. 1997;  156 382-8
  • 13 Henry P J. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.  Br J Pharmacol. 1993;  110 435-41
  • 14 Turner N C, Power R F, Polak J M, Bloom S R, Dollery C T. Endothelin-induced contractions of tracheal smooth muscle and identification of specific endothelin binding sites in the trachea of the rat.  Br J Pharmacol. 1989;  98 361-6
  • 15 Van den Broucke C O, Lemli J A. Pharmacological and chemical investigation of thyme liquid extracts.  Planta Med. 1981;  41 129-35
  • 16 Meister A, Bernhardt G, Christoffel V, Buschauer A. Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: discrimination between drug and ethanol effects.  Planta Med. 1999;  65 512-6
  • 17 Boskabady M H, Aslani M R, Kiani S. Relaxant effect of Thymus vulgaris on guinea-pig tracheal chains and its possible mechanism(s).  Phytother Res. 2006;  20 28-33
  • 18 Wienkötter N. Pharmakologische Untersuchungen zum Spasmolytischen Wirkmechanismus von Thymian-haltigen Extrakten: Beeinflussung des β2-adrenergen Systems [disseration]. Münster; University of Münster 2006
  • 19 Wienkötter N, Begrow F, Kinzinger U, Schierstedt D, Verspohl E J. The effect of thyme extract on beta2-receptors and mucociliary clearance.  Planta Med. 2007;  73 629-35
  • 20 Devadason P S, Henry P J. Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.  Br J Pharmacol. 1997;  121 253-63
  • 21 Bremnes T, Paasche J D, Mehlum A, Sandberg C, Bremnes B, Attramadal H. Regulation and intracellular trafficking pathways of the endothelin receptors.  J Biol Chem. 2000;  23 17 596-604
  • 22 Freedman N J, Ament A S, Oppermann M, Stoffel R H, Exum S T, Lefkowitz R J. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity.  J Biol Chem. 1997;  272 17 734-43
  • 23 Wu-Wong J R, Chiou W J, Magnuson S R, Opgenorth T J. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.  Biochim Biophys Acta. 1994;  1224 288-94
  • 24 Chun M, Lin H Y, Henis Y I, Lodish H F. Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor.  J Biol Chem. 1995;  270 10 855-60
  • 25 Burgess G, Hoogkamer H, Collings L, Dingemanse J. Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil.  Eur J Clin Pharmacol. 2008;  64 43-50
  • 26 Sudoh K, Yuyama H, Noguchi Y, Fujimori A, Ukai M, Ohtake A. et al . Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.  J Cardiovasc Pharmacol. 2004;  44 390-3
  • 27 Clozel M, Breu V, Gray G A, Kalina B, Löffler B M, Burri K. et al . Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.  J Pharmacol Exp Ther. 1994;  270 228-35

Prof. Dr. E. J. Verspohl

Department Pharmacology

Institute for MedicinalChemistry

University of Münster

Hittorfstr. 58–62

48149 Münster

Germany

Fax: +49-251-83-32144

Email: verspoh@uni-muenster.de

    >